Annual EBITDA
$10.89B$119.00M+1.10%
Summary
- Current Value
- As of today, TMO annual EBITDA is $10.89B, up +1.10% on
- Historical Performance
- TMO annual EBITDA is down -8.54% over the past 3 years, up +6.53% over the past 5 years
- All-Time High Comparison
- TMO annual EBITDA is currently -15.65% below its historical high of $12.91B set on
- 3-Year Low Comparison
- TMO annual EBITDA is +1.10% above its 3-year low of $10.77B reached on
- Sector Comparison
- TMO annual EBITDA is higher than 98.50% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $10.89B | +1.1% | -8.5% | +6.5% | +443.3% | |
| Quarterly EBITDA | $3.18B | +13.1% | +12.6% | +7.0% | +429.0% | |
| TTM EBITDA | $12.16B | +10.5% | +11.9% | -8.8% | +439.4% | |
| Price | $692.74 | +20.7% | +48.5% | +8.9% | +1409.2% | |
| PE Ratio | 36.55 | +10.3% | +19.6% | +23.8% | +110.8% | |
| Annual Revenue | $44.56B | +3.9% | -0.8% | +38.3% | +328.7% | |
| Annual EPS | $17.74 | +7.2% | +0.5% | +11.0% | +603.0% | |
| Annual EBIT | $8.11B | +5.8% | -4.9% | +2.7% | +541.3% | |
| Annual Net Income | $6.72B | +6.0% | -3.5% | +5.4% | +581.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.91B | N/A | -8.5% |
| 5Y | $12.91B | -15.7% | |
| All | $12.91B | -15.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $10.77B | +1.1% | |
| 5Y | $10.22B | N/A | +6.5% |
| All | $7.15M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of TMO?
- As of today, TMO annual EBITDA is $10.89B
- What is 1-year change in TMO annual EBITDA?
- TMO annual EBITDA is up +1.10% year-over-year
- What is 3-year change in TMO annual EBITDA?
- TMO annual EBITDA is down -8.54% over the past 3 years
- How far is TMO annual EBITDA from its all-time high?
- TMO annual EBITDA is currently -15.65% below its historical high of $12.91B set on December 31, 2021
- How does TMO annual EBITDA rank versus sector peers?
- TMO annual EBITDA is higher than 98.50% of companies in Healthcare sector
- When is TMO next annual earnings release?
- The next annual earnings release for TMO is on
EBITDA Formula
Quarterly EBITDA
$3.18B$101.00M+3.28%
Summary
- Current Value
- As of today, TMO quarterly EBITDA is $3.18B, up +3.28% on
- Historical Performance
- TMO quarterly EBITDA is up +13.11% year-over-year, up +12.63% over the past 3 years
- All-Time High Comparison
- TMO quarterly EBITDA is currently -14.82% below its historical high of $3.74B set on
- 3-Year Low Comparison
- TMO quarterly EBITDA is +25.11% above its 3-year low of $2.55B reached on
- Sector Comparison
- TMO quarterly EBITDA is higher than 98.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $3.18B | +3.3% | +13.1% | +12.6% | +7.0% | |
| Annual EBITDA | $10.89B | – | +1.1% | -8.5% | +6.5% | |
| TTM EBITDA | $12.16B | +3.1% | +10.5% | +11.9% | -8.8% | |
| Price | $692.74 | +12.9% | +20.7% | +48.5% | +8.9% | |
| PE Ratio | 36.55 | +10.8% | +10.3% | +19.6% | +23.8% | |
| Quarterly Revenue | $12.14B | +1.2% | +9.1% | +14.8% | +30.1% | |
| Quarterly EPS | $4.64 | -0.9% | +8.5% | +5.0% | -3.2% | |
| Quarterly EBIT | $2.46B | +8.7% | +14.3% | +24.7% | +4.9% | |
| Quarterly Net Income | $1.73B | -0.9% | +6.5% | +1.9% | -9.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.18B | at high | |
| 3Y | $3.18B | at high | |
| 5Y | $3.70B | -14.0% | |
| All | $3.74B | -14.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.71B | +17.6% | |
| 3Y | $2.55B | +25.1% | |
| 5Y | $2.55B | +25.1% | |
| All | -$331.10M | +1061.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of TMO?
- As of today, TMO quarterly EBITDA is $3.18B
- What is TMO quarterly EBITDA most recent change?
- TMO quarterly EBITDA was up +3.28% on September 26, 2026
- What is 1-year change in TMO quarterly EBITDA?
- TMO quarterly EBITDA is up +13.11% year-over-year
- How far is TMO quarterly EBITDA from its all-time high?
- TMO quarterly EBITDA is currently -14.82% below its historical high of $3.74B set on December 31, 2020
- How does TMO quarterly EBITDA rank versus sector peers?
- TMO quarterly EBITDA is higher than 98.46% of companies in Healthcare sector
- When is TMO next earnings release?
- The next earnings release for TMO is on
EBITDA Formula
TTM EBITDA
$12.16B$369.00M+3.13%
Summary
- Current Value
- As of today, TMO TTM EBITDA is $12.16B, up +3.13% on
- Historical Performance
- TMO TTM EBITDA is up +10.47% year-over-year, up +11.93% over the past 3 years
- All-Time High Comparison
- TMO TTM EBITDA is currently -8.75% below its historical high of $13.32B set on
- 3-Year Low Comparison
- TMO TTM EBITDA is +14.89% above its 3-year low of $10.58B reached on
- Sector Comparison
- TMO TTM EBITDA is higher than 98.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $12.16B | +3.1% | +10.5% | +11.9% | -8.8% | |
| Annual EBITDA | $10.89B | – | +1.1% | -8.5% | +6.5% | |
| Quarterly EBITDA | $3.18B | +3.3% | +13.1% | +12.6% | +7.0% | |
| Price | $692.74 | +12.9% | +20.7% | +48.5% | +8.9% | |
| PE Ratio | 36.55 | +10.8% | +10.3% | +19.6% | +23.8% | |
| TTM Revenue | $47.35B | +2.2% | +8.3% | +9.1% | +21.2% | |
| TTM EPS | $18.95 | +2.0% | +9.5% | +24.2% | -12.0% | |
| TTM EBIT | $9.15B | +3.5% | +11.5% | +23.0% | -15.3% | |
| TTM Net Income | $7.10B | +1.5% | +7.9% | +19.8% | -17.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $12.16B | at high | |
| 3Y | $12.16B | at high | |
| 5Y | $13.32B | N/A | -8.8% |
| All | $13.32B | -8.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $11.00B | N/A | +10.5% |
| 3Y | $10.58B | +14.9% | |
| 5Y | $10.58B | +14.9% | |
| All | -$36.90M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of TMO?
- As of today, TMO TTM EBITDA is $12.16B
- What is TMO TTM EBITDA most recent change?
- TMO TTM EBITDA was up +3.13% on September 26, 2026
- What is 1-year change in TMO TTM EBITDA?
- TMO TTM EBITDA is up +10.47% year-over-year
- How far is TMO TTM EBITDA from its all-time high?
- TMO TTM EBITDA is currently -8.75% below its historical high of $13.32B set on September 1, 2021
- How does TMO TTM EBITDA rank versus sector peers?
- TMO TTM EBITDA is higher than 98.56% of companies in Healthcare sector
- When is TMO next earnings release?
- The next earnings release for TMO is on
EBITDA Formula
Data Sources & References
- TMO Official Website www.thermofisher.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
- TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
- TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo
